I-Mab
NASDAQ:IMAB

Watchlist Manager
I-Mab Logo
I-Mab
NASDAQ:IMAB
Watchlist
Price: 1.04 USD -1.89% Market Closed
Market Cap: 84.1m USD
Have any thoughts about
I-Mab?
Write Note

Wall Street
Price Targets

IMAB Price Targets Summary
I-Mab

Wall Street analysts forecast IMAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMAB is 6.89 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.

Lowest
Price Target
5.05 USD
386% Upside
Average
Price Target
6.89 USD
562% Upside
Highest
Price Target
8.4 USD
708% Upside
I-Mab Competitors:
Price Targets
688278
Xiamen Amoytop Biotech Co Ltd
1% Upside
002252
Shanghai RAAS Blood Products Co Ltd
9% Downside
MREO
Mereo Biopharma Group PLC
81% Upside
T5O
CytoTools AG
74% Downside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
14% Downside
CCCC
C4 Therapeutics Inc
221% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
44% Upside
KRYS
Krystal Biotech Inc
15% Upside

Revenue
Forecast

Revenue Estimate
I-Mab

For the last 5 years the compound annual growth rate for I-Mab's revenue is -12%.

-12%
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
I-Mab

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
I-Mab

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMAB's stock price target?
Price Target
6.89 USD

According to Wall Street analysts, the average 1-year price target for IMAB is 6.89 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.

Back to Top